Human genetic variation within neural crest enhancers: Molecular and phenotypic implications

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 368, Issue 1620, 2013, Pages

  Rada Iglesias, Alvaro ^a   Prescott, Sara L ^a   Wysocka, Joanna ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chromatin; Cooperativity; Craniofacial; Enhancer; Neural crest; Single nucleotide polymorphism

Indexed keywords

EMBRYONIC DEVELOPMENT; GENE EXPRESSION; GENETIC VARIATION; MOLECULAR ANALYSIS; MORPHOGENESIS; PHENOTYPIC PLASTICITY; POLYMORPHISM; PROTEIN;

CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 1; NR2F1 PROTEIN, HUMAN; PROTEIN BINDING; TFAP2A PROTEIN, HUMAN; TRANSCRIPTION FACTOR AP 2;

ALLELE; ANATOMY AND HISTOLOGY; ANIMAL; CHROMATIN ASSEMBLY AND DISASSEMBLY; CYTOLOGY; ENHANCER REGION; FACE; GENETIC EPIGENESIS; GENETIC VARIABILITY; GENETICS; HUMAN; METABOLISM; MORPHOGENESIS; NEURAL CREST; PHENOTYPE;

ALLELES; ANIMALS; CHROMATIN ASSEMBLY AND DISASSEMBLY; COUP TRANSCRIPTION FACTOR I; ENHANCER ELEMENTS, GENETIC; EPIGENESIS, GENETIC; FACE; GENETIC VARIATION; HUMANS; MORPHOGENESIS; NEURAL CREST; PHENOTYPE; PROTEIN BINDING; TRANSCRIPTION FACTOR AP-2;

EID: 84891453290     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2012.0360     Document Type: Review

References (80)

1. Buecker C, Wysocka J. 2012 Enhancers as information integration hubs in development: lessons from genomics. Trends Genet. 28, 276-284. (doi:10.1016/j.tig.2012.02.008)
2. Bulger M, Groudine M. 2011 Functional and mechanistic diversity of distal transcription enhancers. Cell 144, 327-339. (doi:10.1016/j.cell.2011.01.024)
3. Lagha M, Bothma JP, Levine M. 2012 Mechanisms of transcriptional precision in animal development. Trends Genet. 28, 409-416. (doi:10.1016/j.tig.2012. 03.006)
4. Ong CT, Corces VG. 2012 Enhancers: emerging roles in cell fate specification. EMBO Rep.13, 423-430. (doi:10.1038/embor.2012.52)
5. Spitz F, Furlong EE. 2012 Transcription factors: from enhancer binding to developmental control. Nat. Rev. Genet.13, 613-626. (doi:10.1038/nrg3207)
6. Levine M. 2010 Transcriptional enhancers in animal development and evolution. Curr. Biol. 20, R754-R763. (doi:10.1016/j.cub.2010.06.070)
7. Banerji J, Olson L, Schaffner W.1983 A lymphocytespecific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell 33, 729-740. (doi:10.1016/0092-8674(83)90015-6)
8. Sandmann T, Girardot C, Brehme M, Tongprasit W, Stolc V, Furlong EE. 2007 A core transcriptional network for early mesoderm development in Drosophila melanogaster. Genes Dev. 21, 436-449. (doi:10.1101/gad.1509007)
9. Yanez-Cuna JO, Kvon EZ, Stark A. 2012 Deciphering the transcriptional cis-regulatory code. Trends Genet. 29, 11-22. (doi:10.1016/j.tig.2012.09.007)
10. Zinzen RP, Girardot C, Gagneur J, Braun M, Furlong EE. 2009 Combinatorial binding predicts spatio-temporal cis-regulatory activity. Nature 462, 65-70. (doi:10.1038/nature08531)
11. Halfon MS, Carmena A, Gisselbrecht S, Sackerson CM, Jimenez F, Baylies MK, Michelson AM. 2000 Ras pathway specificity is determined by the integration of multiple signal-activated and tissue-restricted transcription factors. Cell 103, 63-74. (doi:10.1016/ S0092-8674(00)00105-7)
12. Mullen AC et al. 2011 Master transcription factors determine cell-type-specific responses to TGF-b signaling. Cell 147, 565-576. (doi:10.1016/j.cell. 2011.08.050)
13. Trompouki E et al. 2011 Lineage regulators direct BMP and Wnt pathways to cell-specific programs during differentiation and regeneration. Cell 147, 577-589. (doi:10.1016/j.cell.2011.09.044)
14. Li B, Carey M, Workman JL. 2007 The role of chromatin during transcription. Cell 128, 707-719. (doi:10.1016/j.cell.2007.01.015)
15. Lorch Y, LaPointe JW, Kornberg RD.1992 Initiation on chromatin templates in a yeast RNA polymerase II transcription system. Genes Dev. 6, 2282-2287. (doi:10.1101/gad.6.12a.2282)
16. Workman JL, Taylor IC, Kingston RE.1991 Activation domains of stably bound GAL4 derivatives alleviate repression of promoters by nucleosomes. Cell 64, 533-544. (doi:10.1016/0092-8674(91)90237-S)
17. Miller JA, Widom J. 2003 Collaborative competition mechanism for gene activation in vivo. Mol. Cell. Biol. 23, 1623-1632. (doi:10.1128/MCB.23.5.1623-1632.2003)
18. Mirny LA. 2010 Nucleosome-mediated cooperativity between transcription factors. Proc. Natl Acad. Sci. USA 107, 22534-22539. (doi:10.1073/pnas.0913805107)
19. Voss TC et al. 2011 Dynamic exchange at regulatory elements during chromatin remodeling underlies assisted loading mechanism. Cell 146, 544-554. (doi:10.1016/j.cell.2011.07.006)
20. Zaret KS, Carroll JS. 2011 Pioneer transcription factors: establishing competence for gene expression. Genes Dev. 25, 2227-2241. (doi:10.1101/gad.176826.111)
21. Biddie SC et al. 2011 Transcription factor AP1 potentiates chromatin accessibility and glucocorticoid receptor binding. Mol. Cell 43, 145-155. (doi:10.1016/j.molcel.2011.06.016)
22. de la Serna IL, Ohkawa Y, Berkes CA, Bergstrom DA, Dacwag CS, Tapscott SJ, Imbalzano AN. 2005 MyoD targets chromatin remodeling complexes to the myogenin locus prior to forming a stable DNAbound complex. Mol. Cell. Biol. 25, 3997-4009. (doi:10.1128/MCB.25.10.3997-4009.2005)
23. Lupien M, Eeckhoute J, Meyer CA, Wang Q, Zhang Y, Li W, Carroll JS, Liu XS, Brown M. 2008 FoxA1 translates epigenetic signatures into enhancerdriven lineage-specific transcription. Cell 132, 958-970. (doi:10.1016/j.cell.2008.01.018)
24. Liber D, Domaschenz R, Holmqvist PH, Mazzarella L, Georgiou A, Leleu M, Fisher AG, Labosky PA, Dillon N. 2010 Epigenetic priming of a pre-B cell-specific enhancer through binding of Sox2 and Foxd3 at the ESC stage. Cell Stem Cell 7, 114-126. (doi:10.1016/ j.stem.2010.05.020)
25. Xu J, Pope SD, Jazirehi AR, Attema JL, Papathanasiou P, Watts JA, Zaret KS, Weissman IL, Smale ST. 2007 Pioneer factor interactions and unmethylated CpG dinucleotides mark silent tissuespecific enhancers in embryonic stem cells. Proc. Natl Acad. Sci. USA 104, 12377-12382. (doi:10.1073/pnas.0704579104)
26. Gualdi R, Bossard P, Zheng M, Hamada Y, Coleman JR, Zaret KS.1996 Hepatic specification of the gut endoderm in vitro: cell signaling and transcriptional control. Genes Dev.10, 1670-1682. (doi:10.1101/ gad.10.13.1670)
27. Bossard P, Zaret KS.1998 GATA transcription factors as potentiators of gut endoderm differentiation. Development 125, 4909-4917.
28. Merika M, Thanos D. 2001 Enhanceosomes. Curr. Opin. Genet. Dev.11, 205-208. (doi:10.1016/ S0959-437X(00)00180-5)
29. Wu WH, Hampsey M.1999 Transcription: common cofactors and cooperative recruitment. Curr. Biol. 9, R606-R609. (doi:10.1016/S0960-9822(99)80385-6)
30. Krivega I, Dean A. 2012 Enhancer and promoter interactions-long distance calls. Curr. Opin. Genet. Dev. 22, 79-85. (doi:10.1016/j.gde.2011.11.001)
31. Kagey MH et al. 2010 Mediator and cohesin connect gene expression and chromatin architecture. Nature 467, 430-435. (doi:10.1038/nature09380)
32. Zentner GE, Scacheri PC. 2012 The chromatin fingerprint of gene enhancer elements. J. Biol. Chem. 287, 30888-30896. (doi:10.1074/jbc.R111. 296491)
33. Heintzman ND et al. 2009 Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459, 108-112. (doi:10.1038/nature07829)
34. Rada-Iglesias A, Bajpai R, Swigut T, Brugmann SA, Flynn RA, Wysocka J. 2011 A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470, 279-283. (doi:10.1038/ nature09692)
35. Visel A et al. 2009 ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457, 854-858. (doi:10.1038/nature07730)
36. Thurman RE et al. 2012 The accessible chromatin landscape of the human genome. Nature 489, 75-82. (doi:10.1038/nature11232)
37. Gammill LS, Bronner-Fraser M. 2003 Neural crest specification: migrating into genomics. Nat. Rev. Neurosci. 4, 795-805. (doi:10.1038/ nrn1219)
38. Sauka-Spengler T, Bronner-Fraser M. 2008 A gene regulatory network orchestrates neural crest formation. Nat. Rev. Mol. Cell Biol. 9, 557-568. (doi:10.1038/nrm2428)
39. Cordero DR, Brugmann S, Chu Y, Bajpai R, Jame M, Helms JA. 2010 Cranial neural crest cells on the move: Their roles in craniofacial development. Am. J. Med. Genet. A 155A, 270-279. (doi:10.1002/ajmg.a.33702)
40. Minoux M, Rijli FM. 2010 Molecular mechanisms of cranial neural crest cell migration and patterning in craniofacial development. Development 137, 2605-2621. (doi:10.1242/dev.040048)
41. Birnbaum S et al. 2009 Key susceptibility locus for nonsyndromic cleft lip with or without cleft palate on chromosome 8q24. Nat. Genet. 41, 473-477. (doi:10.1038/ng.333)
42. Passos-Bueno MR, Ornelas CC, Fanganiello RD. 2009 Syndromes of the first and second pharyngeal arches: a review. Am. J. Med. Genet. A 149A, 1853-1859. (doi:10.1002/ajmg.a.32950)
43. Bajpai R et al. 2010 CHD7 cooperates with PBAF to control multipotent neural crest formation. Nature 463, 958-962. (doi:10.1038/nature08733)
44. Rada-Iglesias A, Bajpai R, Prescott S, Brugmann SA, Swigut T, Wysocka J. 2012 Epigenomic annotation of enhancers predicts transcriptional regulators of human neural crest. Cell Stem Cell 11, 633-648. (doi:10.1016/j.stem.2012.07.006)
45. Lin FJ, Qin J, Tang K, Tsai SY, Tsai MJ. 2011 Coup d'Etat: an orphan takes control. Endocr. Rev. 32, 404-421. (doi:10.1210/er.2010-0021)
46. de Croze N, Maczkowiak F, Monsoro-Burq AH. 2011 Reiterative AP2a activity controls sequential steps in the neural crest gene regulatory network. Proc Natl Acad Sci USA 108, 155-160. (doi:10.1073/pnas.1010740107)
47. Tsai SY, Tsai MJ.1997 Chick ovalbumin upstream promoter-transcription factors (COUP-TFs): coming of age. Endocr. Rev.18, 229-240. (doi:10.1210/er.18.2.229)
48. Creyghton MP et al. 2010 Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl Acad. Sci. USA 107, 21931-21936. (doi:10.1073/pnas.1016071107)
49. Reddy TE et al. 2012 Effects of sequence variation on differential allelic transcription factor occupancy and gene expression. Genome Res. 22, 860-869. (doi:10.1101/gr.131201.111)
50. Karczewski KJ, Tatonetti NP, Landt SG, Yang X, Slifer T, Altman RB, Snyder M. 2011 Cooperative transcription factor associations discovered using regulatory variation. Proc. Natl Acad. Sci. USA 108, 13353-13358. (doi:10.1073/pnas.1103105108)
51. Maurano MT et al. 2012 Systematic localization of common disease-associated variation in regulatory DNA. Science 337, 1190-1195. (doi:10.1126/ science.1222794)
52. Degner JF et al. 2012 DNase I sensitivity QTLs are a major determinant of human expression variation. Nature 482, 390-394. (doi:10.1038/nature10808)
53. McDaniell R et al. 2010 Heritable individual-specific and allele-specific chromatin signatures in humans. Science 328, 235-239. (doi:10.1126/science.1184655)
54. Gaulton KJ et al. 2010 A map of open chromatin in human pancreatic islets. Nat. Genet. 42, 255-259. (doi:10.1038/ng.530)
55. Frankel N, Davis GK, Vargas D, Wang S, Payre F, Stern DL. 2010 Phenotypic robustness conferred by apparently redundant transcriptional enhancers. Nature 466, 490-493. (doi:10.1038/nature09158)
56. Hong JW, Hendrix DA, Levine MS. 2008 Shadow enhancers as a source of evolutionary novelty. Science 321, 1314. (doi:10.1126/science.1160631)
57. Lettice LA et al. 2003 A long-range Shh enhancer regulates expression in the developing limb and fin and is associated with preaxial polydactyly. Hum. Mol. Genet.12, 1725-1735. (doi:10.1093/hmg/ddg180)
58. Kleinjan DA, van Heyningen V. 2005 Long-range control of gene expression: emerging mechanisms and disruption in disease. Am. J. Hum. Genet. 76, 8-32. (doi:10.1086/426833)
59. Stitzel ML et al. 2010 Global epigenomic analysis of primary human pancreatic islets provides insights into type 2 diabetes susceptibility loci. Cell Metab.12, 443-455. (doi:10.1016/j.cmet.2010.09.012)
60. Pittman AM et al. 2010 Allelic variation at the 8q23.3 colorectal cancer risk locus functions as a cisacting regulator of EIF3H. PLoS Genet. 6. (doi:10.1371/journal.pgen.1001126)
61. Ahmadiyeh N et al. 2010 8q24 prostate, breast, and colon cancer risk loci show tissue-specific longrange interaction with MYC. Proc. Natl Acad. Sci. USA 107, 9742-9746. (doi:10.1073/pnas.0910668107)
62. Sotelo J et al. 2010 Long-range enhancers on 8q24 regulate c-Myc. Proc. Natl Acad. Sci. USA 107, 3001-3005. (doi:10.1073/pnas.0906067107)
63. Wasserman NF, Aneas I, Nobrega MA. 2010 An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer. Genome Res. 20, 1191-1197. (doi:10.1101/gr.105361.110)
64. Sakabe NJ, Savic D, Nobrega MA. 2012 Transcriptional enhancers in development and disease. Genome Biol.13, 238. (doi:10.1186/ gb-2012-13-1-238)
65. Rahimov F et al. 2008 Disruption of an AP-2a binding site in an IRF6 enhancer is associated with cleft lip. Nat. Genet. 40, 1341-1347. (doi:10.1038/ ng.242)
66. Peter IS, Davidson EH. 2011 Evolution of gene regulatory networks controlling body plan development. Cell 144, 970-985. (doi:10.1016/j. cell.2011.02.017)
67. Gellon G, McGinnis W.1998 Shaping animal body plans in development and evolution by modulation of Hox expression patterns. Bioessays 20, 116-125. (doi:10.1002/(SICI)1521-1878(199802)20:2,116:: AID-BIES4.3.0.CO;2-R)
68. King MC, Wilson AC.1975 Evolution at two levels in humans and chimpanzees. Science 188, 107-116. (doi:10.1126/science.1090005)
69. Wray GA, Hahn MW, Abouheif E, Balhoff JP, Pizer M, Rockman MV, Romano LA. 2003 The evolution of transcriptional regulation in eukaryotes. Mol. Biol. Evol. 20, 1377-1419. (doi:10.1093/molbev/ msg140)
70. Carroll SB. 2008 Evo-devo and an expanding evolutionary synthesis: a genetic theory of morphological evolution. Cell 134, 25-36. (doi:10.1016/j.cell.2008.06.030)
71. Stark A et al. 2007 Discovery of functional elements in 12 Drosophila genomes using evolutionary signatures. Nature 450, 219-232. (doi:10.1038/ nature06340)
72. Wittkopp PJ et al. 2009 Intraspecific polymorphism to interspecific divergence: genetics of pigmentation in Drosophila. Science 326, 540-544. (doi:10.1126/ science.1176980)
73. Johannsdottir B, Thorarinsson F, Thordarson A, Magnusson TE. 2005 Heritability of craniofacial characteristics between parents and offspring estimated from lateral cephalograms. Am. J. Orthod. Dentofacial Orthop.127, 200-207. (doi:10.1016/j. ajodo.2004.07.033)
74. Hall BK, Miyake T.1992 The membranous skeleton: the role of cell condensations in vertebrate skeletogenesis. Anat. Embryol. (Berl) 186, 107-124.
75. Lengele B, Schowing J, Dhem A.1996 Chondroid tissue in the early facial morphogenesis of the chick embryo. Anat. Embryol. (Berl) 193, 505-513.
76. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B. 2002 The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17-29. (doi:10.1016/S0092-8674(01)00622-5)
77. Yoshida CA et al. 2004 Runx2 and Runx3 are essential for chondrocyte maturation, and Runx2 regulates limb growth through induction of Indian hedgehog. Genes Dev.18, 952-963. (doi:10.1101/ gad.1174704)
78. Mallarino R, Grant PR, Grant BR, Herrel A, Kuo WP, Abzhanov A. 2011 Two developmental modules establish 3D beak-shape variation in Darwin's finches. Proc. Natl Acad. Sci. USA 108, 4057-4062. (doi:10.1073/pnas.1011480108)
79. Schneider RA, Helms JA. 2003 The cellular and molecular origins of beak morphology. Science 299, 565-568. (doi:10.1126/science.1077827)
80. Abzhanov A, Protas M, Grant BR, Grant PR, Tabin CJ. 2004 Bmp4 and morphological variation of beaks in Darwin's finches. Science 305, 1462-1465. (doi:10.1126/science.1098095)